Showing results (301-310 of 546) with videos related to

Sort By:
Pageof 55
Thrombosis and Haemostasis|June 28, 1982
The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation productsJ Soria, C Soria, O Bertrand, et al.
Minerva Anestesiologica|May 10, 2006
Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003C M Samama, R Djoudi, T Lecompte, et al.
Ophthalmology|September 1, 1994
Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factorsA Glacet-Bernard, A Chabanel, F Lelong, et al.
Pathologie-Biologie|December 1, 1977
[Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)]L Bara, M Samama, G Bilski-Pasquier, et al.
Journal of Human Evolution|December 24, 2022
Early evidence for bear exploitation during MIS 9 from the site of Schöningen 12 (Germany)Ivo Verheijen, Britt M Starkovich, Jordi Serangeli, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 1, 1981
[Chronic disseminated intravascular coagulation in a case of ventricular aneurysm. Correction by low-dose heparin]M Stamama, C Starkman, M H Horellou, et al.
Journal of Human Evolution|December 1, 2020
Early anthropogenic use of hematite on Aurignacian ivory personal ornaments from Hohle Fels and Vogelherd caves, GermanyElizabeth C Velliky, Patrick Schmidt, Ludovic Bellot-Gurlet, et al.
Thrombosis and Haemostasis|February 26, 2004
Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole bloodGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Thrombosis and Haemostasis|May 6, 2011
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinuxM Wolzt, M M Samama, S Kapiotis, et al.
Annales De Medecine Interne|January 1, 1988
[Acquired factor VII inhibitor: treatment using high-dose immunoglobulins, corticotherapy and plasma exchange]A Delmer, G Andreu, M H Horellou, et al.
Pageof 55